EUVIMEDEUVIMED entdecken
Crossref

Pseudoginsenoside F11 alleviates atherosclerosis by regulating SIRT3-mediated deacetylation of SOD2

Wenjie Bi, Rong Dong, Jin Ren, Chenghao Bi, Fanyu Zhao, Kairui Liu, Ying Yang, Daquan Chen, Songsong Wang, Liwen Han

Phytomedicine · 2026-10 · 160 · 158606

DOI: 10.1016/j.phymed.2026.158606 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026-10. Verfasst von Wenjie Bi und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, China; Sch…. Hauptthemen laut MEDLINE: Ginsenosides, Sirtuin 3, Atherosclerosis, Superoxide Dismutase. Die Arbeit nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jinan Science and Technology Bureau, Yantai University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Endothelial protection has emerged as a promising therapeutic strategy for cardiovascular diseases such as atherosclerosis (AS). However, no endothelial-targeted therapeutic drugs have yet been used in clinical practice. Pseudoginsenoside F11 (PF11), a characteristic saponin from Panax quinquefolius L., exerts cardiovascular protective effects, yet the mechanisms underlying its endothelial protective effects in AS remain unclear. PURPOSE This study aimed to investigate the mechanisms by which PF11 protects vascular endothelium from injury and thereby ameliorates AS. METHODS Mouse and zebrafish models were used to validate the ameliorative effect of PF11 on AS. Metabolomics, transcriptome sequencing (RNA-seq) and mitochondrial function assays were used to investigate the regulatory effect of PF11 on vascular endothelial cell injury. Pharmacological inhibition, gene silencing, and target-capture assays were used to elucidate the potential molecular mechanisms by which PF11 protects vascular endothelium. RESULTS PF11 significantly attenuated vascular injury in high-fat diet (HFD)-induced mouse and zebrafish models of AS, as indicated by reduced vessel wall thickening and decreased vascular lipid deposition. Moreover, PF11 markedly alleviated palmitic acid-induced endothelial cell dysfunction by reducing apoptosis and inflammatory responses, restoring NO production, and suppressing mitochondrial oxidative stress, thereby exerting vasoprotective effects. Mechanistically, PF11 directly bound to mitochondrial SIRT3 in endothelial cells. This interaction enhanced SIRT3-mediated deacetylation of the downstream protein SOD2, thereby counteracting the HFD-induced increase in intracellular ROS. Following pharmacological inhibition of SIRT3, PF11 restored mitochondrial ROS scavenging in endothelial cells, whereas SIRT3 knockdown attenuated its protective effects on endothelial injury. CONCLUSIONS This study demonstrated that PF11 exerted significant protective effects against AS. The protective effects of PF11 were closely associated with SIRT3 targeting, which preserved mitochondrial function and attenuated HFD-induced vascular endothelial injury. These findings suggest that PF11 may be a promising therapeutic candidate for endothelial injury and offer a novel endothelial-centered perspective for the treatment of AS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GinsenosidesSirtuin 3AtherosclerosisSuperoxide DismutaseAnimalsZebrafishMiceSuperoxide Dismutase 2AcetylationMaleMice, Inbred C57BLEndothelium, VascularEndothelial CellsDiet, High-FatHumansPanaxOxidative StressDisease Models, AnimalMitochondriaApoptosis

Stichwörter der Autor:innen

AtherosclerosisMitochondriaOxidative stressPseudoginsenoside F11SIRT3Vascular endothelium

Substanzen

GinsenosidesSirtuin 3Superoxide DismutaseSuperoxide Dismutase 2pseudoginsenoside F11Sirt3 protein, mouse

Autor:innen und Institutionen

  • School of Pharmacy & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, China; School of Pharmacy, Nanjing Medical University, Nanjing, 211166, China.
  • School of Pharmacy & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, China; Taian 88 Hospital, China RongTong Medical Healthcare Group Co. Ltd., Taia…
  • School of Pharmacy & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, China; Institute of Pharmacy, Shandong University of Traditional Chinese Medicin…
  • School of Pharmacy & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, China.
  • Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, 264005, China.
  • School of Pharmacy & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, China. Electronic address: wangsongsong@sdfmu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Jinan Science and Technology Bureau
  • Yantai University
  • Health Commission of Shandong Province

Zitieren

APA

Bi, W., Dong, R., Ren, J., Bi, C., Zhao, F., Liu, K., Yang, Y., Chen, D., Wang, S., & Han, L. (2026). Pseudoginsenoside F11 alleviates atherosclerosis by regulating SIRT3-mediated deacetylation of SOD2. Phytomedicine, 160, 158606. https://doi.org/10.1016/j.phymed.2026.158606

Vancouver

Bi W, Dong R, Ren J, Bi C, Zhao F, Liu K, et al. Pseudoginsenoside F11 alleviates atherosclerosis by regulating SIRT3-mediated deacetylation of SOD2. Phytomedicine. 2026;160:158606. doi:10.1016/j.phymed.2026.158606

BibTeX
@article{Bi2026,
  author = {Bi, Wenjie and Dong, Rong and Ren, Jin and Bi, Chenghao and Zhao, Fanyu and Liu, Kairui and Yang, Ying and Chen, Daquan and Wang, Songsong and Han, Liwen},
  title = {Pseudoginsenoside F11 alleviates atherosclerosis by regulating SIRT3-mediated deacetylation of SOD2},
  journal = {Phytomedicine},
  year = {2026},
  volume = {160},
  pages = {158606},
  doi = {10.1016/j.phymed.2026.158606}
}
Kostenlos starten →